Listed injectables makers · PDF → LIMS compliant migration
Shanghai-listed injectables and oral-formulations manufacturers need to migrate historical PDF reports into a next-generation LIMS compliantly. This is the typical deployment scenario for that profile.
About this page: this is a deployment scenario for a typical customer profile — not the specific numbers of any one customer. Figures below come from internal testing and early-deployment observations; they do not represent any particular customer’s actuals.
Customer profile
Shanghai-listed integrated pharmaceutical enterprises producing large-volume parenterals, small-volume injectables, and oral formulations under stringent GMP regulation. Customers in this profile typically:
- Need to migrate historical QC data (held as PDFs) into a next-generation LIMS / MES
- In parallel, must establish a compliant ongoing data flow (“PDF → structured data → LIMS”) for routine QC
- Operate primarily on Waters Empower and Agilent ChemStation
Pain points
- Large historical PDF backlog: thousands to tens of thousands of reports — manual entry isn’t economically feasible
- Tight LIMS go-live window: migration and process cutover must complete inside a defined window
- Compliance scope: the migration itself must satisfy NMPA’s “Drug Records and Data Management Requirements”
ChromaParse deployment pattern
- Plan: Team SaaS + planned Local Pro upgrade — for a smooth transition
- Coverage: Waters Empower, Agilent ChemStation
- Private library: Several internal report templates
- Integration: Bulk historical PDF migration + ongoing QC data flow
Value and expected outcomes
Figures below come from internal testing and early-deployment observation; actual gains depend on backlog size and template coverage:
- Historical PDF reports (thousands to tens of thousands) bulk structured-imported into the new LIMS
- Routine QC compliance with full audit trail; complete pointer chain between values and source PDFs
- Two-person review burden materially reduced, freeing QC time for method development
Other scenarios
Small-molecule CDMOs serving multinational pharma run Empower and OpenLab side by side; QC teams process hundreds of chromatography PDFs every day. This is the typical deployment scenario for that profile.
Listed manufacturers of pharmaceutical and specialty-chemical intermediates and APIs need a compliant data flow from chromatography PDFs into LIMS under NMPA's data-integrity rules. This is the typical deployment scenario for that profile.
Listed specialty-API CDMOs run four different chromatograph vendors across plants — cross-site data normalisation is the core pain. This is the typical deployment scenario for that profile.
Want to be the next adopter?
Get in touch with sales — we'll scope a deployment for your environment.